Intrinsiqs

Is Progyny, Inc. overvalued?

Progyny, Inc. (PGNY) looks undervalued — trading about 70% below its fair value.

Undervalued
Current price $36.18 Fair value $61.65
Price
$36.18
Fair value
$61.65
Current P/E
26.4
Normal P/E
45.0
Market cap
$2.66B
Dividend yield
0.0%
Return on equity
20.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares PGNY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.